THE Therapeutic Goods
Administration has released the
latest version of its Medicines
Safety Update, including a section
on progressive multifocal
leukoencephalopathy which has
been associated with the use of
immunomodulatory medicines.
There’s also advice that the
Product Information for thyroxine
has recently been updated to
include a precaution about the
increased risk of osteoporotic
fracture associated with excessive
thyroxine doses.
The TGA has also noted 51
adverse event reports since 2002 of
serious electrolyte disturbances
associated with oral bowel
cleansing products which are part
of the preparation for a range of
medical and diagnostic procedures.
The full Medicines Safety Update
is available on the TGA website at
tga.gov.au/hp/msu-2013-01.htm.The above article was sent to subscribers in Pharmacy Daily's issue from 04 Feb 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Feb 13
MEDICATION management platform MedAdvisor Limited (MDR) showed strong financial performance for the quarter concluded on 31 Mar 2024, with operating revenue up 42% to $24.2 million from $17 million for the same period last year.
PHARMACIES in regional areas need a restructure of the 8CPA Community Service Obligation (CSO) to help fund them to support their workforce and deliver services, says the Remote and Isolated Pharmacist Association Australia (RIPAA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.